Frequently Asked Questions
About Clinical Trials

Enroll in Clinical Trials

Keeping in tradition with U of U Health’s commitment to advance the fields of medicine and surgery, our physicians are focusing on regenerative medicine as the next frontier in treating cardiovascular disease. Researchers within the Cardiovascular Center estimate cell therapy will be FDA-approved within three years. The goal of this therapy is to give cells back to the heart in order for it to grow stronger, work harder, and function more like a younger heart. Currently, studies include the potentiality of injecting cardiac repair cells into patients’ hearts to improve function.

This is the first trial of its kind in the United States, providing heart patients who have limited or no other options with a viable treatment. Using some of the best imaging technology, researchers have been able to see improvements in patients within six months after injecting their own cells directly into the left ventricle of the heart during minimally invasive surgery.

To contact us, please use the contact number provided.

Cardiothoracic Surgeons

Craig H. Selzman, MD

Patient Rating:


4.8 out of 5

Dr. Craig Selzman is a Professor of Surgery and Chief of the Division of Cardiothoracic Surgery at the University of Utah who specializes in the care of patients requiring heart surgery. He earned his undergraduate degree at Amherst College and medical degree at Baylor College of Medicine. He received his General and Cardiothoracic Surgery training... Read More


University Campus
University of Utah Hospital
50 N Medical Drive
Salt Lake City, UT 84132

Patient Experience

Clinical Trials

  • CV-201
    Keywords: Stem Cell, Heart Failure, Ischemic Cardiomyopathy
    Status: Recruiting
  • AC6 Trial
    Keywords: Gene Therapy, Heart Failure, Cardiomyopathy
    Status: Active, not recruiting
  • TEVA CEP-41750
    Keywords: Stem cells, Heart Failure, Regenerative Medicine, Cardiology, Gene therapy
    Status: Recruiting
  • Aastrom HF 2B
    Keywords: Stem Cells
    Status: Completed
    Keywords: Stem Cell, Heart, Coronary Artery Disease, Ejection Fraction, ischemic heart disease
    Status: Recruiting
  • LVAD and Stem Cells
    Keywords: Heart Failure, LVAD, Stem Cells, Bridge to Transplant, Destination Therapy, Myocardial Recovery
    Status: Recruiting